Detalhe da pesquisa
1.
Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
World J Urol
; 42(1): 178, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507101
2.
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
BJU Int
; 132(2): 160-169, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36648124
3.
External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.
World J Urol
; 41(3): 619-625, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249120
4.
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
World J Urol
; 41(11): 3195-3203, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811732
5.
Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study.
World J Urol
; 41(2): 483-489, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36633650
6.
Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial.
World J Urol
; 41(9): 2381-2388, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480491
7.
Nephrometry scores to predict oncological outcomes following partial nephrectomy (UroCCR Study 70).
World J Urol
; 41(12): 3559-3566, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792008
8.
A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study-UroCCR 80).
Eur Radiol
; 33(9): 6513-6521, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37004570
9.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
10.
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test.
BJU Int
; 129(3): 356-363, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33751774
11.
Essential elements of anaesthesia practice in ERAS programs.
World J Urol
; 40(6): 1299-1309, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839862
12.
Self-reported functional assessment after treatment for prostate cancer: 5-year results of the prospective cohort VICAN.
Future Oncol
; 18(14): 1733-1744, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172586
13.
Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
Urol Int
; 106(2): 171-179, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34569540
14.
Metastatic hormone sensitive prostate cancer: local treatment strategies.
World J Urol
; 39(2): 327-337, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588203
15.
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment.
World J Urol
; 39(11): 4055-4065, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666225
16.
Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy.
Int J Hyperthermia
; 38(1): 1633-1638, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775896
17.
Comparison between Zumsteg classification and Briganti nomogram for the risk of lymph-node invasion before radical prostatectomy.
World J Urol
; 38(7): 1719-1727, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31560121
18.
Fully sexual-sparing robot-assisted cystectomy: a step-by-step surgical technique.
BJU Int
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586930
19.
Extent of positive surgical margins following radical prostatectomy: impact on biochemical recurrence with long-term follow-up.
BMC Urol
; 19(1): 37, 2019 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31092240
20.
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.
World J Urol
; 36(11): 1727-1740, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855698